Abstract: Leprosy is aneasily recognizable disease due to its dermato-neurological manifestations. It must be present in the physician's diagnostic repertoire, especially for those working in endemic areas. However, leprosy reaction is not always easily recognized by non-dermatologists, becoming one of the major problems in the management of patients with leprosy, as it presents clinical complications characterized by infl ammatory process, accompanied by pain, malaise and sometimes the establishment or worsening of the patient's disabilities. We report the case of a patient with type-1 periorbital reaction admitted to the hospital, diagnosed and treated as facial cellulitis, whose late diagnosis may have contributed to the appearance or worsening of facial neuritis.
INTRODUCTION
Leprosy is an infectious, chronic, and communicable disease caused by Mycobacterium leprae. It affects mainly the skin and peripheral nerves. 1 Due to the ample clinical variations of the disease, the list of differential diagnoses is quite complex, often leading to delays in its identifi cation and subsequent treatment.¹ Among the primary challenges, those are patients who initially present with type I or type II reactional episodes, thus requiring early diagnosis and institution of specifi c treatments in order to reduce the chance of developing physical disabilities and sequelae, which may negatively impact their social and professional lives. 2 We present here the case of a patient who was primarily diagnosed with facial cellulitis and only later diagnosed with leprosy.
CASE REPORT
A sixty-seven-year-old male patient, married, born in Brejo Santo/CE, coming from Petrolina/PE, was admitted to the emergency room with a history of pruritus and redness in the left eye for the last 6 months. Also, 25 days prior to the admission,the patient developed periorbital edema and an erythematous plaque on the forehead and left periorbital region. He sought medical attention and was prescribed prednisone 60mg/day. At the time, he also reported numbness onthe left hand, associated with a lesion similar to the one on his face.The patient denied any systemic symptoms. Physical examination on admission showed an erythematous-infi ltrated plaque reaching the left side of the forehead and edema on the periorbital region and nasal dorsum to the left ( Figure 1 ). He was admitted with a diagnosis of periorbital cellulitis, prescribed treatment with Ampicillin + Sulbactam and laboratory tests were requested. Upon admission he presented 13.2g/dL hemoglobin; 39.4% hematocrit; 5,900 x10 9 L leukocytes (67.9% neutrophils); 272,000 x10 9 L platelets; 142mEq/L sodium; 5.2-mEq/Lpotassium; 19 mg/dL BUN; 1.0 mg/dL creatinine. The patient received antibiotic treatment for 10 days without clinical improvement, hence a CT scan was ordered and the diagnostic hypothesis was once more facial cellulitis, which prompted a proposal for antibiotic change (Figures 2 and 3) . Nonetheless, a sensitivity test was performed on the plaque area and loss of thermal sensitivity was detected all over the lesion, as well as on the hand lesion, leading to the diagnosis of borderline tuberculoid leprosy (BTD) in reaction.
Bacilloscopy of the lesions was negative. Both lesions were biopsied and anatomopathological results revealed periadnexal and perineural granulomatous chronic dermatitis. With an established diagnosis of BTD in reaction, the patient was prescribed prednisone 60 mg/day and referred to a dermatologist, who started treatment with specifi c multibacillarypolychemotherapy (rifampicin, clofazimine and dapsone). Prednisone 60mg/day was maintained, with gradual tapering off after the reaction abated and in 15 days the patient showed improvement (Figure 4 ). Forty-fi ve days after the treatment was started the patient presented marked recovery, although the presence of lagophthalmos on the left side was noticed, prompting physical therapy and close monitoring ( Figure 5 ).
DISCUSSION
Reaction episodes are acute phenomena affecting skin and peripheral nerves. They may occur before, during or after the treatment and are the leading cause of nerve damage and disability secondary to leprosy. 3 Reactions might be of type I, also known as reverse reaction or type II, namely erythema nodosum. Type I reactions present signs of acute infl ammation such as pain, erythema, infi ltration and edema of pre-existing lesions; also, the appearance of new lesions, papules and plaques (usually erythematous and adjacent to pre-existing lesions) may occur. Lesions may be single or multiple and are oftenulcerated. 3, 4 Reactions occur in dimorphic leprosy forms (DL) such as borderline tuberculoid (BT), borderline (BB), and borderline lepromatous (BL). Type II reactions or erythema nodosum are associated with general symptoms such as fever, painful lymphadenopathy and malaise, manifesting as papules or painful, erythematous nodules. They occur in lepromatous (LL) and borderline lepromatous (BL) forms. 4 In type 1 reaction, presented by the patient in this report, there are manifestations that can mimic erysipelas, cellulitis, drug eruptions, urticaria, psoriasis, sarcoidosis, lymphomas, sudden peripheral facial paralysis and even leprosy relapse itself. 5 The complete mechanisms involved in its genesis are yet unknown.It is accepted, however, that it results from an imbalance between pro-infl ammatory cytokines (gamma interferon and interleukin-2, mainly) and anti-infl ammatory cytokines (especially TGF beta and interleukin 10). 6 In the clinical case in question, the patient was initially diagnosed and treated as facial cellulitis, because of the intense infl ammatory process he presented, without taking into consideration the reported paresthesia or the lesion on the left hand, which was similar to the facial one. Due to the lack of improvement after the therapy was introduced, bacilloscopies of the lesion and conventional sites (earlobes and elbow) were later performed with negative results, as 
